5th International Electronic Conference on Medicinal Chemistry
the chair
Proud of the success of the previous editions, it is our pleasure to invite you to contribute to the 5th International Electronic Conference on Medicinal Chemistry. The Conference, organized and sponsored by the peer-reviewed journal Pharmaceuticals, will be held online during the month of November 2019.
The aim of the Conference is to gather researchers from all over the world and encourage discussions on any scientific field related to drug discovery and development. Posting presentations, videos, or posters disclosing your recent outstanding results enables you to take advantage of the conference to promote your work among thousands of your peers. Participation, as an author or a visitor, is ABSOLUTELY FREE; simply register on the home page.
This year, as the conference sponsor, Pharmaceuticals will be giving an award for the Best Presentation as elected by the scientific committee, which consists of 500 Swiss Francs. We hope you will be able to join this exciting event and enjoy a stimulating exchange with your peers around the world. Also, we will launch a Special Issue covering the event.
On behalf of our dynamic editorial staff and active scientific committee, we warmly invite you to join us during this fifth edition and we look forward to posting your contributions.
Meet the Event Chair
Important Dates
- Abstract submission deadlineOct 25, 2019
- Abstract acceptance notificationNov 01, 2019
- Full file submission deadlineNov 01, 2019
Meet Our Speakers
Prof. Dr. Leonidas A. Phylactou
Chief Executive Medical Director, The Cyprus Institute of Neurology & Genetics, PO Box 23462, 1683 Nicosia, Cyprus;
Leonidas Phylactou was born in Paphos, Cyprus on 2nd January 1970. He studied Medical Biochemistry at the University of Birmingham in the UK and then did a PhD in Molecular Genetics and Gene Therapy in the same University, although most of the time was spent at the University of Connecticut Health Centre in the USA. He then moved back to the UK, to the University of Oxford as a post-doctoral scientist, where he set up a team working on gene therapy for Myotonic Dystrophy.
In 1998 he established a research group at the Cyprus Institute of Neurology and Genetics working on the gene function and gene therapy. In 2005 he was appointed Head of the Department of Molecular Genetics, Function and Therapy in which, apart from the research activities, he is responsible for diagnostic services in Medical Genetics. His research interests focus on the gene therapy for muscular dystrophy, the identification of biomarkers in Myotonic Dystrophy and the investigation of molecular causes for inherited diseases.
Since November 2015 he is the Chief Executive Medical Director of the Cyprus Institute of Neurology and Genetics (CING) and the Provost of the Cyprus School of Molecular Medicine, the postgraduate school of the CING.
Dr. Simone Lucarini
Assistant Professor at the Department of Biomolecular Sciences, Section of Chemistry, School of Pharmacy, University of Urbino, Italy;
Simone Lucarini studied Chemistry at the University of Bologna (Italy), where he graduated in 2000. He received his PhD in Chemistry and Pharmaceutical Sciences at the University of Urbino (Italy) in 2005. In 2003, he spent a year at the University of Kansas (USA) working with Prof. Kristin Bowman-James in the field of “anion recognition”.
In 2005 he moved to the University of Tokyo (Japan) as a winner of the JSPS long term fellowship to run a post-doc with Prof. Shu Kobayashi. During this period, he developed a new synthetic method, based on an enantioselective desymmetrization of meso-aziridines, which is plausibly applicable to the production of (-) - shikimic acid, a key intermediate for the synthesis of Tamiflu.
In 2007 he came back to Urbino as a post-doc and in 2013 became assistant professor in Medicinal Chemistry.
His research interests range from Medicinal, Supramolecular and Organic Chemistry in order to obtain new original methods for obtaining achiral and chiral molecules of pharmaceutical-biological interest, together with the development of new synthetic methods of potential industrial interest. In detail, he is developing new methodologies for the synthesis of natural products, containing the indole nucleus, with potential antitumor and antibacterial activities. Recently, he is playing with the chemistry of sugars designing and synthesizing new glycolipids as biocompatible antibacterial agents and as emulsifying agents for pharmaceutical applications.
From 2008 is professor of drug analysis at the school of pharmacy at Urbino and from 2012 is a member of the organizing committee of the European School of Medicinal Chemistry.
Dr. Claudio Ferrante
Università degli Studi G. d'Annunzio Chieti e Pescara | UNICH · Department of Pharmacy;
The pharmacological research activity of Prof. C. Ferrante is focused on the following main research fields:
Role of endogenous peptides on food intake and energy expenditure control; Protective effects of medicinal plants and extracts, with particular regards to inflammatory and neurodegenerative diseases; Pharmacology of central monoaminergic system; Optimization of preclinical pharmacological models for the study of the mechanism of action of drugs.
Prof. C. Ferrante is co-author of 67 publications in international journals surveyed by ISI Science Citation Index.
Dr. Giustino Orlando
University of G. d'Annunzio Chieti and Pescara, Chieti, Italy;
Dr. Mariia Nesterkina
Odessa National Polytechnic University, Odessa, Ukraine;
Mariia Nesterkina studied Chemistry at I.I. Mechnikov Odessa National University (Ukraine), where she graduated in 2014. Then she successfully defended her PhD thesis in Bioorganic Chemistry at the Institute of Bioorganic Chemistry and Petrochemistry (Kyiv, Ukraine) in 2017. Her research interests range from Bioorganic Chemistry – synthesis of natural occurring compounds with their further physico-chemical analysis – to Pharmacology – instigation of anticonvulsant, analgesic, anti-inflammatory activity of novel compounds. Additionally, she studies the influence of synthesized derivatives on phospholipids of artificial membranes and lipids isolated from the rat stratum corneum. Since 2019 she is Associate Professor at Odessa National Polytechnic University (Ukraine).
Prof. Dr. Maria Emília De Sousa
Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências, Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira 228, 4050-313, Porto, Portugal, Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR/CIMAR), Universidade do Porto, Terminal de Cruzeiros do Porto de Leixões, Avenida General Norton de Mato;
Dr. Maria M. M. Santos
Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisboa, Portugal;
Maria M. M. Santos is Principal Researcher of the group of Medicinal Chemistry of the Faculty of Pharmacy of the University of Lisbon, she is member of the EXECUTIVE COMMITTEE of the medicinal chemistry division of Portuguese Society of Chemistry (SPQ), and she is the PORTUGUESE NAO LIAISON OFFICER of the European Federation of Medicinal Chemistry (EFMC). The ultimate goal of her research group is the development of general synthetic methods and strategies, and their application to the synthesis of bioactive molecules (e.g. NMDA receptor antagonists and p53 activators).
Dr. Maurício Homem-de-Mello
Universidade de Brasília, Brasilia, Brazil;
Mauricio Homem-de-Mello is a full time professor at Universidade de Brasília, in Brazil. His Ph.D. degree in Toxicology was obtained in 2009, at Universidade de São Paulo. He is an experimental toxicologist that has moved to the “in silico” research. Since his early studies the interest in action mechanisms of drugs was the main focus. The computational approach is now the tool that he is going deeper.
Dr. Alfredo Berzal-Herranz
Department of Molecular Biology, Instituto de Parasitología y Biomedicina López-Neyra, (IPBLN-CSIC), PTS Granada, Av del Conocimiento 17, 18016 Granada, Spain;
Dr. Ievgeniia Iermak
University of São Paulo;
Dr. Ievgeniia Iermak is the research associate in the Laboratory of Biophotonics, University of Sao Paulo, Brazil. Her research and teaching activities are dedicated to studying molecular mechanisms of cancer treatment, microbial control, and efficacy of pharmaceutical formulations. Ievgeniia has a life-long interest in advanced imaging techniques application in life sciences and pharmaceutics.
Mr. Christos Tsagkaris
University of Crete;
Christos Tsagkaris is studying Medicine in the University of Crete (Heraklion, Greece). He is affiliated to the Association of European Cancel Leagues (ECL) as a Youth Ambassador for Greece and he currently serves as Editor in Chief in NovelMeds, a health science magazine focusing on Sustainable Health and in the European Student Think Tank. He has participated in several scientific conferences and events as an organizer, ambassador or presenter. He is also involved in several EU focused students associations including the Bringing Europeans Together Association - Greece and the Students Association for International Affairs. He has a keen interest on Space Medicine and Medical Humanities.
Andrea Camera is studying Medicine in the University of Brescia (Brescia, Italy). Ana Sofia Mota is studying Medicine in the University of Lisbon Faculty of Medicine (Lisbon, Portugal) and Maria Lydakaki is studying Law in the University of Athens, Faculty of Law. They have all conducted research in their fields and share a keen interest in Space Science and in mutual aspects of Technology, Medicine and Law.
Dr. Šárka Pospíšilová
Regional Centre of Advanced Technologies and Materials (RCPTM), Palacký University;
Šárka Pospíšilová is a Ph.D student at Regional Centre of Advanced Technologies and Materials (RCPTM), Palacký University in Olomouc, Czech Republic. She obtained her Doctor of Pharmacy degree (PharmDr.) at University of Veterinary and Pharmaceutical Sciences in Brno, Czech Republic. Dr. Pospíšilová deepened her professional knowledge at several research-fellowships abroad, such as the Faculty of Pharmacy of the University of Ljubljana (Slovenia), the Department of Biological Sciences of the Cork Institute of Technology (Ireland), the Center for Agricultural Research of the Hungarian Academy of Sciences (Hungary), etc. Her research focuses on the investigation of antimicrobial activity of newly synthesized compounds, including (aza)naphthalenes, thiosemicarbazones, salicylamides, derivatives of carbamic acid and metal complexes. These types of compounds as antimicrobially multi-target agents tested against wide spectrum of microorganisms, such as staphylococci, enterococci, mycobacteria, and various plant pathogens, seem to be promising for overcoming resistance/multi-drug resistance of microorganisms. Her current research activities are mainly devoted to anti-biofilm active compounds and interaction with quorum-sensing. She is an author/co-author of 2 patent applications, 11 peer-reviewed scientific publications, and many contributions at international conferences and workshops.
Ms. Cristina Almeida
University of Porto;
Dr. Patrícia Rijo
Universidade Lusófona de Humanidades e Tecnologias, Lisbon, Portugal;
Patrícia Dias de Mendonça Rijo has a graduation in Chemistry by the Faculty of Sciences at the University of Lisbon (FCUL), and Master and PhD degrees in Pharmaceutical and Therapeutic Chemistry by the Faculty of Pharmacy at the University of Lisbon (FFUL). Currently, she is Assistant Professor at the School of Sciences and Health Technologies (ECTS) at the Universidade Lusófona de Humanidades e Tecnologias (ULHT, Lisbon, Portugal) since 2001, where she is responsible for the Coordination of several disciplines in related domains of Chemistry, namely, Medicinal Chemistry and Pharmacognosy. Moreover, she is a member of the Scientific Council of ECTS (ULHT). She has focused her research in the medicinal chemistry, phytochemistry and pharmacognosy areas with particular emphasis in Natural Products Chemistry. She published more than seventy papers in international peer-reviewed journals and has over two hundred communications (oral and panel) presented at both national and international meetings and conferences. In addition, she has two international registered patents.
Ms. Eduarda Fernandes
University of Minho;
Eduarda Fernandes graduated in Biomedical Sciences by University of Beira Interior in 2014 and is a MSc in Biophysics and Bionanosystems from University of Minho (2017). From 2017 to 2018 she was promotor and founder of the project “EyeOnDrug”, that was based on developing nanotechnological solutions for drug and formulation profiling, for which she was awarded with an entrepreneur fellowship funded by IAPMEI, Portugal. In 2018 she continued developing this work as a research fellow in Centre of Physics of the Universities of Minho and Porto (CF-UM-UP), where she is currently a first year PhD student in Materials Engineering. The scientific research activity of Eduarda has been focused on the application of several biophysical and physical‐chemical techniques to characterize the interaction between bioactives, including newly-synthesized drugs, and biomimetic interfaces to establish a pharmacokinetic profiling to support drug design/development and formulation development. Among other activities, Eduarda has participated in several international and national conferences presenting 7 oral communications as first author (2 of which as invited speaker) and 5 posters, two of which was awarded as the Best Poster. Moreover, she has published 3 papers (first author of 2 papers) in journals of high impact and quartile 1 in the area of pharmaceutics, molecular sciences and analytical chemistry. She is also co-author of two book chapters (accepted for publication in “Functional lipid nanosystems in cancer” and “Nanoparticles for Brain Drug Delivery”).
Dr. Edeildo Ferreira da Silva-Júnior
Federal University of Alagoas;
Edeildo Ferreira da Silva-Júnior studied Pharmacy at the Federal University of Alagoas, Maceió – Brazil. Subsequently, he received his Master’s degree in Pharmaceutical Sciences by the Federal University of Alagoas, Brazil, as well. Since his Master degree, he is working in the medicinal chemistry of Neglected Tropical Diseases (NTD’s), collecting valuable experiences on the researches addressed to the development of novel synthetic compounds with activity against Leishmania spp. and Trypanosoma cruzi, in association with collaborators from the University of Strasbourg – France. He has Ph.D. degree in Chemistry and Biotechnology, with focus on the Medicinal and Biological Chemistry, obtained at the Federal University of Alagoas. During his Ph.D., he developed part of his project and thesis at the Institute of Pharmacy and Biochemistry from the Johannes Gutenberg University of Mainz, Germany. Current, he holds a post-doctoral position at the Federal University of Alagoas, where he acts as Project-Leader and Laboratory-Head at the Institute of Pharmaceutical Sciences. Furthermore, he develops projects involving collaborators from the Johannes Gutenberg University of Mainz and Würtzburg University (Germany). He has several patents and high-qualified publications in organic and medicinal chemistry fields, such as Bioorganic Chemistry, Molecules, Current Topics in Medicinal Chemistry, Biosensors & Bioelectronics, Bioorganic & Medicinal Chemistry, Current Drug Metabolism, Biomedicine & Pharmacotherapy, and others.
- A. ECMC-5
- B. Posters
- C. keynote Presentation
Sponsors and Partners
Organizer
Media partner
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe that authors should retain the copyright to their research works. Hence, by submitting a contribution to this conference, the authors retain the copyright of their contribution, but they grant MDPI AG the non-exclusive right to publish this contribution online on the Sciforum.net platform. This means the authors can easily submit their contribution to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).